Julie Yang
Directeur/Bestuurslid bij Khloris Biosciences, Inc.
Oorsprong van het eerstegraads netwerk van Julie Yang
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts.
14
| Subsidiary | Investment Managers | 14 |
Triumvira Immunologics, Inc.
 Triumvira Immunologics, Inc. Pharmaceuticals: MajorHealth Technology Triumvira Immunologics, Inc. develops and manufactures pharmaceutical products. The company was founded by Jonathan Bramson in 2015 and is headquartered in Hamilton, Canada.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Leaps By Bayer /US/
5
| Subsidiary | Investment Managers | 5 |
Khloris Biosciences, Inc.
 Khloris Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Khloris Biosciences, Inc. operates as biotechnology company. The firm offers drug discovery, vaccine and cell therapies for treatment and prevention of cancer. The company was founded by Lynne A. Bui and Joseph C. Wu in June 2017 and is headquartered in Mountain View, CA.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Julie Yang via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BIOGEN INC. | Pharmaceuticals: Major | Private Equity Analyst | |
| Rochester Christian University | College/University | Undergraduate Degree | |
Eventide Asset Management LLC
 Eventide Asset Management LLC Investment ManagersFinance Eventide Asset Management LLC (Eventide) is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. The firm was founded in 2008 by Finni Kuruvilla, Jason Myhre, Roben John, David Barksdale and Anil Thomas. Eventide provides portfolio management for registered mutual funds and offers non-discretionary Model Allocations and Models to financial intermediaries such as wrap fee program sponsors. | Investment Managers | Analyst-Equity | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
| Boston University | College/University | Masters Business Admin | |
| University of Cambridge | College/University | Graduate Degree Graduate Degree | |
| The University of Texas at Austin | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| Tufts University | College/University | Undergraduate Degree Graduate Degree | |
| University of Gottingen | College/University | Graduate Degree | |
Abingworth Management, Inc.
 Abingworth Management, Inc. Investment ManagersFinance Abingworth Management, Inc. invests in life sciences and biomedical companies. The firm's investment in enables technologies, devices and instrumentation as well as companies developing products in therapeutic areas. The company was founded in 1973 and is headquartered in Menlo Park, CA. | Investment Managers | Private Equity Investor | |
Sanofi Ventures
 Sanofi Ventures Investment ManagersFinance Sanofi Ventures (Sanofi) is a venture capital subsidiary of Sanofi founded in 2001. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| Harvard Medical School | College/University | Doctorate Degree | |
Axxam SpA
 Axxam SpA Miscellaneous Commercial ServicesCommercial Services Axxam SpA provides pharmaceuticals services. The firm specializes in molecular biology, electrophysiology, cellular and biochemical systems. The company was founded by Stefan Lohmer and Alessandro Sidoli in November 2001 and is headquartered in Bresso, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
Mcmaster Innovation Park
 Mcmaster Innovation Park Miscellaneous Commercial ServicesCommercial Services Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Guru Gobind Singh Indraprastha University | College/University | Undergraduate Degree | |
| DICE THER | Biotechnology | Director/Board Member | |
| APPILI THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Teckro, Inc.
 Teckro, Inc. Packaged SoftwareTechnology Services Teckro, Inc. offers a solution that transforms clinical trials making all relevant information instantly accessible to every active member of the study. The company is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
| AZITRA, INC. | Pharmaceuticals: Major | Director/Board Member | |
Amfora, Inc.
 Amfora, Inc. BiotechnologyHealth Technology Amfora, Inc. develops biotechnologies for nutritionally enhanced forage crops. The company was founded by Jonathan Burbaum and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
StrideBio, Inc.
 StrideBio, Inc. BiotechnologyHealth Technology Stridebio, Inc. focuses on creating and developing novel adeno-associated viral vector technologies. The company was founded by Aravind Asokan, Mavis Agbandje-McKenna and Patrick Ritschel and is headquartered in Durham, NC. | Biotechnology | Director/Board Member | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| PROMETHEUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Sound Agriculture Co.
 Sound Agriculture Co. Chemicals: AgriculturalProcess Industries Sound Agriculture Co. engages in the development of crop protection and crop enhancement products. Its Rapid Discovery platform focuses on finding solutions that increase the sustainability, productivity, and healthiness of food supply. The company was founded by Eric Davidson and Travis Bayer in 2013 and is headquartered in Emeryville, CA. | Chemicals: Agricultural | Director/Board Member Director/Board Member | |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Aro Biotherapeutics Co. operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics products. It specializes in oncology, drug discovery, drug development, licensing, drug delivery, sirna, immunology, bispecifics, protein conjugation, protein therapeutics and protein engineering services. The company was founded by Karyn O?Neil and Susan Dillon in 2018 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Leaps by Bayer
 Leaps by Bayer Investment ManagersFinance Leaps by Bayer is venture investment unit of Bayer AG (Xetra: BAYN) founded in 2015. The firm is headquartered in Leverkusen, Germany. | Investment Managers | Private Equity Investor Director/Board Member | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
DICE Molecules SV, Inc.
 DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
| KYVERNA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Triumvira Immunologics USA, Inc.
 Triumvira Immunologics USA, Inc. Miscellaneous Commercial ServicesCommercial Services Triumvira Immunologics USA, Inc. develops and manufactures novel T cell therapies for cancer. The company is based in Austin, TX and has subsidiaries in Canada. Paul Lammers has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
| SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Vesigen, Inc.
 Vesigen, Inc. BiotechnologyHealth Technology Vesigen, Inc. develops groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular vesicle delivery technology. The company is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| VIGIL NEUROSCIENCE, INC. | Biotechnology | Director/Board Member | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Director/Board Member | |
Kojin Therapeutics, Inc.
 Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Incendia Therapeutics, Inc.
 Incendia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Incendia Therapeutics, Inc. develops a novel class of anti-cancer therapies. The company is based in Boston, MA. The company was founded in 2003 by Laurent Audoly, Colin Glenn Begley, Olga Granaturova, Guy Travis Clifton. Laurent Audoly has been the CEO since 2003. | Pharmaceuticals: Major | Director/Board Member | |
Mestag Therapeutics Ltd.
 Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Financial Conglomerates | Director/Board Member | |
Totus Medicines, Inc.
 Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Transition Bio, Inc.
 Transition Bio, Inc. BiotechnologyHealth Technology Transition Bio, Inc. is a company based in Watertown, MA that is developing technologies for biomolecular condensate analysis. The company's proprietary drug discovery platform, CondensomicsTM, utilizes droplet microfluidics and machine learning to map and modulate condensates in molecular detail. The company's goal is to build a drug discovery engine based on the latest advancements in biophysics and artificial intelligence. Transition Bio has been founded by Sarah Teichmann, David A. Weitz, Peter H. St George-Hyslop, and Tuomas Knowles. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 38 |
| Verenigd Koninkrijk | 5 |
| Canada | 5 |
| Duitsland | 3 |
| Israël | 2 |
Sectoraal
| Health Technology | 24 |
| Consumer Services | 14 |
| Finance | 7 |
| Commercial Services | 7 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 129 |
| Private Equity Investor | 27 |
| Corporate Officer/Principal | 26 |
| Undergraduate Degree | 23 |
| President | 14 |
Sterkste connecties
| Insiders | |
|---|---|
| Jürgen Eckhardt | 34 |
| Cynthia Collins | 27 |
| Ronald Renaud | 24 |
| Shaan Gandhi | 22 |
| Lucio Iannone | 17 |
| Brian Bloom | 15 |
| Ryan D. Teksten | 15 |
| Lee Cooper | 13 |
| Allyson S. Rinderle | 12 |
| Paimun Amini | 10 |
| Lynne Bui | 9 |
| Joy Ghosh | 8 |
| Paul Lammers | 8 |
| Luca Issi | 7 |
| Ritika Mahal | 7 |
- Beurs
- Insiders
- Julie Yang
- Bedrijfsconnecties